Table 2.
Adverse Event | Curcumin | Placebo |
---|---|---|
Related or possibly related | ||
Flatulence, constipation, diarrhea, or nausea | 7 | 7 |
Headache | 1 | 1 |
Warming or redness of face | 2 | |
Tingling of tongue/mouth | 2 | |
Dry mouth | 1 | |
Skin irritation | 1 | |
Eye redness, dryness, or swelling | 2 | |
Likely or definitely unrelated | ||
Orthopedic injury | 3 | |
Mildly elevated LFTs | 2 | |
Fever | 3 | |
Kidney infection | 1 | 2 |
Urinary tract infection | 2 | 1 |
Upper respiratory infection | 5 | |
IBS, worsening or incident | 2 | |
COVID-19 infection | 2 | |
Sore throat | 2 | |
Tonsillitis, tonsil infection, or tonsillectomy | 1 | 1 |
Hand, foot, and mouth | 1 | |
Streptococcal pharyngitis | 1 | |
Ear infection | 1 | |
Numbness in extremities | 1 | |
Emesis | 2 | |
Influenza | 1 | |
Lightheadedness | 1 | |
Osteomyelitis | 1 | |
Giardia infection | 1 | |
Conjunctivitis | 1 | |
Cholecystectomy surgery | 1 | |
Iron deficiency | 1 | |
Flank pain | 1 | |
Abdominal and pelvic pain | 1 | |
Sinus infection | 1 | |
Strabismus surgery | 1 | |
Yeast infection | 1 | |
Root canal | 1 |
Data are n, including participants who discontinued participation. LFT, liver function tests; IBS, irritable bowel syndrome; COVID-19, coronavirus disease 2019.